(Alliance News) - GSK PLC on Monday said it has teamed up with China's Jiangsu Hengrui Pharmaceuticals Co Ltd in a deal worth up to USD12 billion to develop 12 medicines. Read More
(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warned of an annual outcome below consensus. Read More
(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US regulator. Read More
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory committee last week voted against the overall benefit/risk profile of the drug. Read More
(Alliance News) - Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President Donald Trump said on Wednesday that it was "highly unlikely" that he would fire Federal Reserve Chair Jerome Powell. Read More
(Alliance News) - Stock prices in Europe were largely higher at midday on Friday, though the FTSE 100 pared some earlier gains as a slump from GSK weighed on the index. Read More
(Alliance News) - Stock prices in Europe opened higher early on Friday, with the FTSE 100 almost hitting a new record high, as a swathe of dealmaking was well-received in London. Read More
(Alliance News) - GSK PLC on Thursday noted that the US Food & Drug Administration Oncologic Drugs Advisory Committee voted against the overall benefit/risk profile at the proposed dosage of Blenrep combinations. Read More
(Alliance News) - GSK PLC on Thursday said the prefilled syringe version of its vaccine Shingrix has been approved for use in the US for the prevention of shingles. Read More
(Alliance News) - GSK PLC on Monday said it has submitted a US regulatory application for the expanded use of its Arexvy respiratory syncytial virus vaccine. Read More
(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RSV jab, while South32 warned of an impairment at an aluminium smelter in Mozambique. Read More
(Alliance News) - London's FTSE 100 closed a winning week on the back foot after soft economic growth figures and threats of further tariffs from the US. Read More
(Alliance News) - Stock prices in Europe opened in the green on Wednesday, shaking off a more stern tone from US President Donald Trump on trade policy, though the threat of sector tariffs on copper and pharmaceuticals hit miners and drug makers. Read More
(Alliance News) - The FTSE 100 and sterling rallied, while the bond market calmed on Thursday as Keir Starmer supported his chancellor, reassuring markets that a change at the Treasury wasn't on the cards. Read More
(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease. Read More